• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性儿童癌症幸存者的妊娠结局:日本全国性调查

Pregnancy outcomes in female childhood cancer survivors: Nationwide survey in Japan.

作者信息

Sekiguchi Masaki, Miyoshi Yoko, Kikuchi Norihiko, Sago Haruhiko

机构信息

Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Pediatr Int. 2018 Mar;60(3):254-258. doi: 10.1111/ped.13483. Epub 2018 Feb 12.

DOI:10.1111/ped.13483
PMID:29266574
Abstract

BACKGROUND

The aim of this study was to investigate the outcomes of pregnancy in female childhood cancer survivors (CCS) in Japan, to encourage greater attention to the reproductive health of CCS.

METHODS

This was a retrospective nationwide questionnaire survey of delivery at ≥22 weeks of gestation in CCS at perinatal centers registered with the Japanese Perinatologists Association between 2010 and 2014. We evaluated the maternal characteristics, pregnancy and neonatal outcomes and the relationship between cancer treatment and these outcomes.

RESULTS

The total number of CCS was 61, and the total number of deliveries was 71, corresponding to 0.019% of total deliveries. Regarding cancer, 46% of the patients had had leukemia. Epilepsy was seen in seven (11%). Mean gestational age at delivery was 37.9 weeks. The rate of preterm delivery was 24%. Mean birthweight was 2,718 g. There were three congenital anomalies (4.2%). The rate of preterm delivery was higher and mean birthweight lower in the women treated with radiotherapy than in those without radiotherapy (42% vs 16%, P = 0.025; 2,436 ± 737 g vs 2,827 ± 483 g, P = 0.010). The adjusted OR of radiotherapy for preterm deliveries was 3.53 (P = 0.049).

CONCLUSIONS

Although the number of deliveries by CCS was low in Japan, the pregnancy outcomes were favorable. The important points for managing pregnancy in CCS were preterm delivery as an obstetric complication, especially in CCS who had been treated with radiotherapy, and epilepsy as a maternal complication, which may be related to previously received treatment.

摘要

背景

本研究旨在调查日本儿童癌症幸存者(CCS)的妊娠结局,以促使人们更加关注CCS的生殖健康。

方法

这是一项对2010年至2014年间在日本围产医学会注册的围产中心的CCS进行的回顾性全国问卷调查,调查对象为妊娠≥22周的分娩情况。我们评估了母亲的特征、妊娠和新生儿结局以及癌症治疗与这些结局之间的关系。

结果

CCS总数为61例,分娩总数为71例,占分娩总数的0.019%。关于癌症,46%的患者患有白血病。7例(11%)出现癫痫。分娩时的平均孕周为37.9周。早产率为24%。平均出生体重为2718克。有3例先天性异常(4.2%)。接受放疗的女性早产率高于未接受放疗的女性,平均出生体重低于未接受放疗的女性(42%对16%,P = 0.025;2436±737克对2827±483克,P = 0.010)。放疗导致早产的校正比值比为3.53(P = 0.049)。

结论

虽然日本CCS的分娩数量较少,但妊娠结局良好。管理CCS妊娠的要点是将早产作为产科并发症,尤其是接受过放疗的CCS,以及将癫痫作为母亲并发症,这可能与之前接受的治疗有关。

相似文献

1
Pregnancy outcomes in female childhood cancer survivors: Nationwide survey in Japan.女性儿童癌症幸存者的妊娠结局:日本全国性调查
Pediatr Int. 2018 Mar;60(3):254-258. doi: 10.1111/ped.13483. Epub 2018 Feb 12.
2
Pregnancy outcomes among female childhood, adolescent, and young adult cancer survivors assessed using internet-based nationwide questionnaire surveys in Japan.在日本通过基于互联网的全国性问卷调查对儿童期、青少年期和年轻成年期女性癌症幸存者的妊娠结局进行评估。
J Matern Fetal Neonatal Med. 2022 Dec;35(26):10667-10675. doi: 10.1080/14767058.2022.2155037. Epub 2022 Dec 25.
3
Pregnancy outcomes in children, adolescents, and young adults that survived cancer: A nationwide survey in Japan.日本全国性调查:癌症幸存儿童、青少年和青年的妊娠结局。
J Obstet Gynaecol Res. 2021 Sep;47(9):3352-3361. doi: 10.1111/jog.14909. Epub 2021 Jun 21.
4
Impact of cancer in the management of delivery: 10 years of variations.癌症对分娩管理的影响:10 年变化。
J Matern Fetal Neonatal Med. 2020 Jun;33(12):2006-2011. doi: 10.1080/14767058.2018.1536117. Epub 2018 Dec 20.
5
Perinatal outcomes of women with gestational breast cancer in Australia and New Zealand: A prospective population-based study.澳大利亚和新西兰妊娠期乳腺癌女性的围产结局:一项前瞻性基于人群的研究。
Birth. 2022 Dec;49(4):763-773. doi: 10.1111/birt.12642. Epub 2022 Apr 26.
6
Obstetric and neonatal outcomes in women with pregnancy associated cancer: a population-based study in Lombardy, Northern Italy.意大利北部伦巴第地区妊娠相关癌症患者的产科和新生儿结局:一项基于人群的研究。
BMC Pregnancy Childbirth. 2021 Jan 7;21(1):31. doi: 10.1186/s12884-020-03508-4.
7
Pregnancy in cancer patients and survivors; experience of a university hospital in Turkey.
J Obstet Gynaecol. 2017 Nov;37(8):1015-1019. doi: 10.1080/01443615.2017.1318265. Epub 2017 Jun 26.
8
Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.多囊卵巢综合征与不良产科结局风险:英国一项基于人群的回顾性匹配队列研究。
BMC Med. 2022 Aug 30;20(1):298. doi: 10.1186/s12916-022-02473-3.
9
Pregnancy outcome in female childhood cancer survivors.女性儿童期癌症幸存者的妊娠结局。
Hum Reprod. 2010 May;25(5):1206-12. doi: 10.1093/humrep/deq029. Epub 2010 Feb 19.
10
Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: A cohort study of the Japan Environment and Children's Study.子宫腺肌病妊娠与早产、低出生体重儿及小于胎龄儿风险的关系:一项日本环境与儿童健康研究的队列研究。
Acta Obstet Gynecol Scand. 2019 Mar;98(3):359-364. doi: 10.1111/aogs.13498. Epub 2018 Dec 2.

引用本文的文献

1
Maternal and perinatal outcomes following a diagnosis of Hodgkin lymphoma during or prior to pregnancy: A systematic review.妊娠期间或妊娠前诊断霍奇金淋巴瘤后的母婴围生期结局:一项系统评价。
BJOG. 2023 Mar;130(4):336-347. doi: 10.1111/1471-0528.17347. Epub 2022 Dec 12.
2
Obstetric and perinatal outcomes in female survivors of childhood or adolescent cancer: Protocol of a meta-analysis of population-based cohort studies.儿童或青少年期癌症女性幸存者的产科和围产期结局:基于人群队列研究的荟萃分析方案。
PLoS One. 2022 Sep 2;17(9):e0273561. doi: 10.1371/journal.pone.0273561. eCollection 2022.
3
Obstetrical and Perinatal Outcomes in Female Survivors of Childhood and Adolescent Cancer: A Population-Based Cohort Study.
儿童期和青少年期癌症女性幸存者的产科和围产期结局:基于人群的队列研究。
J Natl Cancer Inst. 2022 Apr 11;114(4):553-564. doi: 10.1093/jnci/djac005.